BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22161356)

  • 1. System-scale network modeling of cancer using EPoC.
    Abenius T; Jörnsten R; Kling T; Schmidt L; Sánchez J; Nelander S
    Adv Exp Med Biol; 2012; 736():617-43. PubMed ID: 22161356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network modeling of the transcriptional effects of copy number aberrations in glioblastoma.
    Jörnsten R; Abenius T; Kling T; Schmidt L; Johansson E; Nordling TE; Nordlander B; Sander C; Gennemark P; Funa K; Nilsson B; Lindahl L; Nelander S
    Mol Syst Biol; 2011 Apr; 7():486. PubMed ID: 21525872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression complex networks: synthesis, identification, and analysis.
    Lopes FM; Cesar RM; Costa Lda F
    J Comput Biol; 2011 Oct; 18(10):1353-67. PubMed ID: 21548810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using evolutional properties of gene networks in understanding survival prognosis of glioblastoma.
    Upton A; Arvanitis TN
    IEEE J Biomed Health Inform; 2014 May; 18(3):810-6. PubMed ID: 24058043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies.
    Ben-Hamo R; Efroni S
    BMC Syst Biol; 2012 Jan; 6():3. PubMed ID: 22236809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A behavioral study of healthy and cancer genes by modeling electrical network.
    Roy T; Barman S
    Gene; 2014 Oct; 550(1):81-92. PubMed ID: 25111257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
    Kunkle B; Yoo C; Roy D
    Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative mining of traditional Chinese medicine literature and MEDLINE for functional gene networks.
    Zhou X; Liu B; Wu Z; Feng Y
    Artif Intell Med; 2007 Oct; 41(2):87-104. PubMed ID: 17804209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks.
    Wang E; Zou J; Zaman N; Beitel LK; Trifiro M; Paliouras M
    Semin Cancer Biol; 2013 Aug; 23(4):279-85. PubMed ID: 23791722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
    Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
    PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
    Leiserson MD; Vandin F; Wu HT; Dobson JR; Eldridge JV; Thomas JL; Papoutsaki A; Kim Y; Niu B; McLellan M; Lawrence MS; Gonzalez-Perez A; Tamborero D; Cheng Y; Ryslik GA; Lopez-Bigas N; Getz G; Ding L; Raphael BJ
    Nat Genet; 2015 Feb; 47(2):106-14. PubMed ID: 25501392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of gene regulatory network dynamics using threshold logic.
    Gowda T; Vrudhula S; Kim S
    Ann N Y Acad Sci; 2009 Mar; 1158():71-81. PubMed ID: 19348633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survival.
    Megchelenbrink W; Katzir R; Lu X; Ruppin E; Notebaart RA
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12217-22. PubMed ID: 26371301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ODE-Based Modeling of Complex Regulatory Circuits.
    Seaton DD
    Methods Mol Biol; 2017; 1629():317-330. PubMed ID: 28623594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network based stratification of major cancers by integrating somatic mutation and gene expression data.
    He Z; Zhang J; Yuan X; Liu Z; Liu B; Tuo S; Liu Y
    PLoS One; 2017; 12(5):e0177662. PubMed ID: 28520777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Mutually Exclusive Gene Sets with Prognostic Value and Novel Potential Driver Genes in Patients with Glioblastoma.
    Gao Q; Cui Y; Shen Y; Li Y; Gao X; Xi Y; Wang T
    Biomed Res Int; 2019; 2019():4860367. PubMed ID: 31815141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KatzDriver: A network based method to cancer causal genes discovery in gene regulatory network.
    Akhavan-Safar M; Teimourpour B
    Biosystems; 2021 Mar; 201():104326. PubMed ID: 33309969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new multiple regression approach for the construction of genetic regulatory networks.
    Zhang SQ; Ching WK; Tsing NK; Leung HY; Guo D
    Artif Intell Med; 2010; 48(2-3):153-60. PubMed ID: 19963359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.